Modification of Apremilast from Pills to Aerosol a Future Concept

Background: Inhaled drugs have been available in the market for several years and for several diseases. Drugs for chronic obstructive pulmonary disease, cystic fibrosis, and diabetes have been used for several years. In the field of drug modification, these drugs range from tablets to aerosol. Metho...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paul Zarogoulidis, Christoforos Kosmidis, Nikolaos Kougkas, Aimilios Lallas, Dimitris Petridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Lutz Freitag, Chrisanthi Sardeli
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/2f545a093e504e6bba8c1b6b243e6a2d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!